Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study

Josep Mallolas*, Daniel Podzamczer, Ana Milinkovic, Pere Domingo, Bonaventura Clotet, Esteve Ribera, Félix Gutiérrez, Hernando Knobel, Jaime Cosin, Elena Ferrer, José Alberto Arranz, Victor Roca, Francesc Vidal, Javier Murillas, Judit Pich, Enric Pedrol, Josep M. Llibre, David Dalmau, Isabel García, Miquel ArandaAna Cruceta, Esteban Martínez, José L. Blanco, Elisa De Lazzari, José M. Gatell

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

81 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study'. Together they form a unique fingerprint.

Medicine & Life Sciences